Corrigendum to "Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice".
[This corrects the article DOI: 10.1155/2016/1405924.].
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Xiao-Wen
0000-0002-3353-7563
XW
Chen
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Xiao-Yan
0000-0002-1178-6817
XY
Du
Department of Gerontology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Yu-Xian
0000-0003-4169-4873
YX
Wang
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Jian-Cheng
0000-0001-8873-9384
JC
Wang
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Wen-Ting
0000-0002-7233-0741
WT
Liu
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Wen-Jing
0000-0003-3674-9278
WJ
Chen
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Hong-Yu
0000-0003-3080-1645
HY
Li
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Fen-Fen
0000-0003-2737-1971
FF
Peng
Department of Emergency, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Zhao-Zhong
0000-0001-9224-2880
ZZ
Xu
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Hong-Xin
0000-0001-8187-7522
HX
Niu
Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China.
Hai-Bo
0000-0001-6891-8916
HB
Long